Best Colon cancer stage 4 doctors in Turkey: TOP 18 doctors

Author of 40+ peer-reviewed publications in tumor biology/immunology and systemic therapy (immunotherapy and targeted therapy); member of the Turkish Medical Oncology Association and the European Head & Neck Society.

Why patients choose Dr. Bülent Karagöz:

• Treatment based on U.S. protocols through Anadolu Medical Center’s strategic collaboration with a leading U.S. institution — Johns Hopkins Medicine.
• 40+ scientific publications in tumor biology/immunology and systemic therapy (immunotherapy and targeted therapy).
• Former department head (GATA) and professor/department chair (Okan University, Turkey) — leadership and clinical experience at major centers.
• Treats solid tumors (e.g., breast, lung, colorectal), applying modern regimens guided by tumor biology.
• Anadolu Medical Center holds ESMO designation and JCI accreditation — meaning the doctor treats according to international protocols, within a multidisciplinary team, with strict safety oversight.

She has been working as an internal medicine specialist and medical oncology specialist at Anadolu Medical Center since 2021.
 

Assoc. Prof. Dr. Abdulcabbar Kartal is a distinguished colorectal and general surgeon practicing at Anadolu Medical Center in Istanbul. With over 17 years of surgical experience, he specializes in colorectal surgery, HIPEC (hyperthermic intraperitoneal chemotherapy) for peritoneal cancers, bariatric surgery, and minimally invasive procedures.

Dr. Kartal graduated from Istanbul University Faculty of Medicine in 2007 and completed his general surgery specialization at Istanbul Şişli Etfal Training and Research Hospital (2007-2013). He served as Assistant Professor at Istanbul Okan University (2016-2020) before receiving his Associate Professor title in 2020. In 2021, he earned the prestigious FEBS-C certification from the European Society of Coloproctology and became a Fellow of the American College of Surgeons (FACS).

Dr. Kartal has published over 40 articles in international peer-reviewed journals and is an active member of the Turkish Society of Colon and Rectal Surgery, European Society of Coloproctology, and Turkish Surgical Association.

Prof. Hüseyin Baloğlu is a pathology specialist at Anadolu Medical Center in Gebze, Kocaeli, Turkey. He focuses on molecular pathology, surgical pathology, and tumour biopsy and diagnostics.

Education and accreditations: MD, GATA Medical School (1986). Pathology specialty training, GATA (1992). Associate Professor (Doçent), GATA (2004). Visiting scholar at Albert Einstein College of Medicine (New York) and Heidelberg University.

Achievements: author of over 600 peer‑reviewed publications. Holds a patent in molecular diagnostics for thyroid cancer. Leads liquid biopsy and precision oncology services.

Dr. Sinan Karaaslan — Medical Oncologist at Anadolu Medical Center (since 2014). He treats breast, colorectal, and genitourinary cancers; in medical oncology since 2003. Member of the Turkish Medical Association, the Turkish Society of Medical Oncology, and the Turkish Lung Cancer Society.

Why patients choose and trust Dr. Karaaslan:

• Manages complex cases of breast, colorectal, and genitourinary cancers — applies modern systemic therapy tailored to the tumor type and stage.
• Member of the Turkish Medical Association, the Turkish Society of Medical Oncology, and the Turkish Lung Cancer Society.
• Author of numerous peer-reviewed articles and patient education materials on chemo- and immunotherapy.
• Practices at a center with ESMO Designated Centre status and JCI accreditation, within a strategic collaboration with Johns Hopkins Medicine International — one of the leading U.S. medical institutions. For patients, this means care aligned with U.S. protocols and the use of advanced equipment.

Professor Yıldırım has published over 80 scientific papers and is a specialist in cancer immunotherapy and targeted therapies at Anadolu Medical Center.

• Holds a professor title from Halic University and is an active lecturer
• Authorized by ESMO – one of Europe's leading oncology bodies
• Fellowship-trained in immunotherapy clinics in London and Israel
• Over 21 years of experience as a medical oncologist

Prof. Şeref Kömürcü is an ECFMG and ESMO-certified medical and breast oncologist with over 20 years of experience. He specializes in solid cancer, breast cancer, colorectal and lung cancer treatment and has held teaching and scientific positions throughout his career. He is a member of several professional organizations.

Dr. Vafi Atalay is an experienced oncological and general surgeon with 17 years in the field. He specializes in pancreatic, colon, rectal, and liver surgeries. He also performs advanced endoscopic procedures. Dr. Atalay has published 31 articles in national and international journals, making valuable contributions to medical literature.

He received the first prize at the 20th Congress Research Paper Competition. He also won the Best Research Award at the 5th Surgeon Research Congress. Dr. Atalay is a member of TSS, the Palestinian Medical Association, and IOA. His active involvement in these organizations shows his dedication to professional growth and surgical excellence.

Specialist Dr. Rahib Hasanov combines international training with personalized oncology treatments, focusing on advanced colon cancer cases.

• Trained at Houston Methodist Hospital in the US
• Specializes in immunotherapies and targeted therapies
• Fellowship in Medical Oncology from Marmara University
• Works with patients from multiple countries
• Incorporates the latest smart drugs into treatments

Dr. Mehmet Doğu Canoğlu is a radiation oncologist. He graduated from Kocaeli University Faculty of Medicine. He completed his residency in radiation oncology at Kocaeli University from 2006 to 2012.

He completed his compulsory service at Diyarbakır Training and Research Hospital. He then worked at Bağcılar Training and Research Hospital and at Medipol Mega University Hospital from 2015 to 2017. Since 2017, he has been a radiation oncologist at Anadolu Medical Center.

Dr. Saban Sec specializes in gastrointestinal cancers, with research on colon cancer prognosis and treatment outcomes.

• Medical oncology specialist with focus on colon, rectum, and stomach cancers
• Published research on tumor localization's impact on colon cancer survival
• Member of Turkish Medical Oncology Association

Assoc. Prof. Atakan Topçu, M.D., is a medical oncologist at Medipol University and Medipol Acıbadem Regional Hospital. He treats solid tumors, including lung, breast, colorectal, gastric, and neuroendocrine cancers. His work also covers targeted therapies, immunotherapy, geriatric oncology, and cancer-related malnutrition, cachexia, and sarcopenia.

He has authored more than 50 peer-reviewed papers. Recent work includes a 2024 Frontiers in Medicine study on geriatric syndromes and a 2023 Future Oncology paper on sarcopenia and anxiety in lung cancer. He has also published on the CONUT score in breast cancer and on malnutrition in HER2-negative metastatic gastric cancer.

Dr. Topçu serves on the Editorial Board of BMC Cancer. He is a member of the Turkish Society of Medical Oncology, ESMO, and the Turkish Geriatrics Society. Education and training: M.D., Uludağ University; residency in Internal Medicine, Marmara University; fellowship in Medical Oncology, Bezmialem Vakıf University.

Dr. Irfan Cicin is a Professor of Medical Oncology at the Trakya University Faculty of Medicine (2015–present). He has over 20 years of medical oncology experience and has held academic roles since 2010.

Education: MD, Istanbul University – Cerrahpaşa (1991–1997). Residency in Internal Medicine, Trakya University (1997–2002). Fellowship in Medical Oncology, Trakya University (2002–2004).

Practice: Medical Oncologist, Trakya University (2005–2008). Medical Oncologist, Elazığ Training and Research Hospital (2008–2010). Associate Professor of Medical Oncology, Trakya University (2010–2015). He previously served as a physician in the Turkish Air Force at Etimesgut Military Hospital (2004–2005).

Dr. Ozden specializes in colon cancer stage 4 with extensive experience in medical oncology.

• Graduated from Istanbul University's English Medical Program
• Completed Internal Medicine Residency at Cerrahpaşa Faculty of Medicine
• Subspecialized in Medical Oncology at Kocaeli University
• Practiced at Şırnak State Hospital and Bağcılar Private Safa Hospital

Assoc. Prof. Ayşe İrem Yasin, M.D., is a medical oncologist who specializes in solid tumors. Her clinical focus includes breast, lung, gastrointestinal, gynecologic, and urologic cancers. She also treats brain and other CNS tumors, soft tissue sarcomas, head and neck cancers, adenocarcinomas, melanoma, Merkel cell carcinoma, and cancers of unknown primary. She practices at Medipol Acıbadem District Hospital (2025–present). She previously worked at Şişli Etfal Training and Research Hospital (2023–2025).

She completed a Medical Oncology fellowship at Bezmialem Vakıf University (2019–2022). This followed an Internal Medicine residency at the same institution (2012–2016). Her international experience includes the Breast Cancer Unit at the University of Piemonte Orientale in Novara (2022). She also trained at Basel University Hospital, Cleveland Clinic, and Harvard Medical School. She holds the ESMO Board Certificate (2022).

Dr. Muhammed Mustafa Atci is an Associate Professor of Medical Oncology at İstinye University, Liv Hospital Topkapı (2025–present). He previously served as Associate Professor and Education Coordinator at Prof. Dr. Cemil Taşcıoğlu City Hospital (2023–2025). He was also a Medical Oncologist there (2018–2021).

He has been a member of ASCO and the Turkish Society of Medical Oncology since 2018. He is the author or co-author of 19 peer-reviewed international papers on colon, breast, gastric, pancreatic, lung, thyroid, sarcoma, and colorectal cancers.

Notable works include a multicentre study on stage IIB colon cancer survival (Journal of Chemotherapy). He also studied the De Ritis ratio for lung metastasis in testicular cancer (Current Urology). His prognostic studies used PET/CT, MSI, lymph node ratio, and metabolic tumor volume.

Specializes in oncologic laparoscopic and robotic surgery for colon and rectum cancer with international training at top institutions.

• Performs laparoscopic hernia surgery and treats complex anorectal diseases
• Trained at University of Colorado Health Science Center and USC Keck School of Medicine
• Fellow of the European Board of Surgery- Emergency Surgery
• Associate Professor at Istanbul Medical Faculty General Surgery